PHC-HOLDINGS
3.9.2021 12:41:06 CEST | Business Wire | Press release
PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President & CEO: John Marotta, hereafter PHCHD), a leading global life science, diagnostics and medical device company, has today announced the appointment of William (Bill) Donnelly and Ivan Tornos as independent external directors, effective September 3, 2021. Both bring significant expertise and executive-level experience at global medical device and life sciences companies.
Mr. Donnelly joins the board with almost 25 years’ experience in the laboratory equipment industry. Mr. Donnelly was most recently the Executive Vice President responsible for Finance, Supply Chain, Manufacturing and IT for Mettler-Toledo. Prior to becoming Executive Vice President, he held various senior executive positions, including Group CFO and as a Global Business Leader for one of Mettler-Toledo’s Divisions. Prior to this he was Chief Financial Officer at Elsag Bailey Process Automation, a market leader in industrial instrumentation and systems for the process control industry. He started his career working as an auditor for Price Waterhouse for 10 years. He is currently an Independent Director of Ingersoll Rand and PST, as well as the Board Chair for John Carroll University.
Mr. Tornos joins the board with almost 25 years’ experience in the medical device industry. Mr. Tornos is currently the Chief Operating Officer at Zimmer Biomet, responsible for overseeing all global businesses and leading the global operations, clinical and medical education, and global R&D functions. Mr. Tornos joined Zimmer Biomet in 2018 as Group President, Orthopedics and was later Group President, Global Businesses and the Americas, before becoming COO earlier this year. Prior to joining Zimmer Biomet, Mr. Tornos was Worldwide President of the Global Urology Group, Medical, and Critical Care Divisions at Becton Dickinson Interventional. He has also held global senior leadership positions in commercial, business development and operations for Covidien International, Baxter International, Johnson & Johnson and Bausch & Lomb.
John Marotta, President, CEO and Chairman of the Board of Directors for PHCHD said, "I am thrilled to have Bill and Ivan join the PHC Holdings Board of Directors. These are two exceptional industry leaders who will add vast experience and capabilities to our board. We are a global company and have set out to add individuals to our board who have deep expertise and diverse perspectives that can help with all aspects of our business. Bill and Ivan’s industry knowledge and strategic guidance will be immensely valuable to the future success of the PHC Group."
Hiro Hirano, Co-Head of Private Equity for KKR Asia and CEO of KKR Japan Limited, and member of the Board of Directors for PHCHD, added, “We are excited about the addition of Bill and Ivan to the PHC Holdings Board of Directors. We have worked to assemble a board with a range of experiences in operational and financial disciplines, and these additions take the board a key step forward in expanding our capabilities. We believe we have the right mix of global leaders who can support the next chapter in the evolution of our business.”
The addition of these new independent external directors follows the recent appointment of Mr. Alan Malus and Ms. Kyoko (Kay) Deguchi in July 2021.
John Marotta added, "Diversity is a high priority for PHC Holdings and all of our operating companies. As we continue to evolve in our journey of diversity and inclusion, we will further evolve our Board of Directors as a part of this initiative.”
About PHC Holdings Corporation
PHC Holdings Corporation is a global healthcare company with subsidiaries including PHC Corporation, Ascensia Diabetes Care, Epredia, and LSI Medience Corporation. Committed to its corporate mission that states, “We contribute to the health of society through our diligent efforts to create healthcare solutions that have a positive impact and improve the lives of people,” the company develops, manufactures, sells and services solutions across diabetes management, healthcare solutions, life sciences and diagnostics. The PHC Group’s consolidated net sales in FY2020 were 306 billion yen with global distribution of products and services in more than 125 countries.
www.phchd.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210903005161/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Global Consumer Trends 2027: Trust, Transparency and Control Take Centre Stage4.11.2026 06:01:00 CET | Press release
Consumers are no longer placing full trust in brands, technology or the future itself. As uncertainty becomes a permanent feature of daily life, greater value is being placed on reliability, transparency and immediate proof of value. Euromonitor International's Top Global Consumer Trends 2027 report finds consumers seeking greater control as uncertainty reshapes consumer behaviour. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103010032/en/ Euromonitor's Top global consumer trends 2027 Drawing on insights from Passport, Euromonitor International's AI-powered market intelligence platform, the report finds consumers looking for balance and control in a world they no longer expect to be certain. Across markets, consumers are placing greater value on reliability, transparency, community and immediate, tangible benefits. “Consumers are no longer simply buying products or services; they're looking for confidence," said Ali Ang
H2SITE Selected for EU Innovation Fund Support to Advance Industrial-Scale Ammonia Cracking in Rotterdam4.11.2026 06:00:00 CET | Press release
The proposed Rotterdam facility would advance the industrial deployment of H2SITE’s hydrogen technology, with a planned production capacity of 20 tons of hydrogen per day. H2SITE has been selected for support from the European Union’s Innovation Fund for the development of an industrial-scale ammonia cracking project in Rotterdam, subject to the formalisation of the grant agreement. The selection marks an important milestone in the company’s work to scale its technology and support the decarbonisation of hard-to-abate industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103379287/en/ Aerial view of the Botlek in Rotterdam. Photo: T.W. van Urk / Shutterstock The project aims to recover and purify hydrogen from imported ammonia close to industrial consumption centres, advancing the industrial deployment of H2SITE’s technology. H2SITE is working closely with industrial stakeholders in Rotterdam to define the project’s
The Estée Lauder Companies Announces Fiscal 2030 Ambition at Its Capital Markets Experience: China Ecosystem Immersion Event4.11.2026 06:00:00 CET | Press release
Sustainable Mid-Single-Digit Organic Net Sales Growth through Fiscal 2030 Adjusted Operating Margin of 16.5%-18.5% in Fiscal 2030Double-Digit Adjusted EPS Growth through Fiscal 2030 The Estée Lauder Companies Inc. (NYSE: EL) today announced its fiscal 2030 ambition at its Capital Markets Experience: China Ecosystem Immersion event in Shanghai, China. Stéphane de La Faverie, President and Chief Executive Officer, and Akhil Shrivastava, Executive Vice President and Chief Financial Officer, outlined the Company’s targets, including its plans to build on the progress of its Beauty Reimagined strategic vision and the execution of its One ELC operating model to deliver sustainable growth while continuing to drive stronger operating leverage and expanded profitability. “We are now entering a new chapter, moving beyond restoring growth to accelerating sustainable, profitable growth and creating long-term value. Our fiscal 2027 outlook reflects this momentum, with accelerating organic sales gro
FPT, Airbus’ Skywise, and Vietnam Airlines Partner to Advance AI-Powered Airline Operations4.11.2026 05:21:00 CET | Press release
FPT, Vietnam Airlines and Skywise, Airbus' digital services company, have signed a Memorandum of Understanding (MoU) to explore the development of AI-powered services. By combining Vietnam Airlines’ operational expertise and data, insights from the Skywise platform, and FPT’s capabilities in aviation technology, systems integration and AI engineering, the collaboration will identify practical AI use cases that could enhance performance, strengthen resilience and support better-informed decision-making. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103646801/en/ The MOU was announced at the Vietnam Aerospace Forum (VAF) in Hanoi on 4 November 2026. The programme will initially focus on fleet reliability, technical operations and disruption management. By combining Skywise’s insights with maintenance planning, parts readiness and flight schedules, the parties will explore AI applications to improve aircraft availability an
IFF Reports Third Quarter 2026 Results3.11.2026 22:30:00 CET | Press release
Delivered Strong Sales, Profit and Cash Flow Performance in Third Quarter 2026Raising Low-End of Full Year 2026 Financial Guidance RangesRecently Completed $500M Share Repurchase AuthorizationFood Ingredients Divestiture Progressing Well and On Track to Close by End of Second Quarter 2027 IFF (NYSE: IFF) reported financial results for the third quarter ended September 30, 2026. Results are presented on a continuing operations basis, excluding the Food Ingredients business and other minor perimeter adjustments (the “Food Ingredients disposal group”), and the Soy Crush, Concentrates, and Lecithin businesses (the “SCL disposal group”). The Food Ingredients disposal group and the SCL disposal group are reported as discontinued operations. Management Commentary “IFF delivered a solid third quarter, with improved sales and profitability across all divisions,” said Erik Fyrwald, CEO of IFF. “Taste and Scent delivered strong top- and bottom-line results, and Health & Biosciences improved modes
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom